[Bolus fibrinolytic therapy in acute myocardial infarction].
Pinelli
G
G
Struttura Complessa di Cardiologia, Ospedale Bellaria, Bologna.
Urbinati
S
S
D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C081981:lanoteplase; C087896:reteplase; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase